
|Articles|January 1, 2005
What's new in PMS?
PMS has been a legitimate diagnosis for several decades, but there are no FDA-approved therapies for it. Off-label use of medications that are FDA-approved for PMDD is common in clinical practice. For patients taking daily SSRIs for anxiety or mood symptoms, premenstrual dose adjustment offers a novel management strategy.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Endometriosis as a systemic disease, with Hugh Taylor, MD
2
FDA accepts extended duration sNDA for MIUDELLA IUD
3
Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal
4
Certolizumab pegol's FDA breakthrough designation, atogepant's LUNA results, deep implant removal guidance
5






